Cancer is a disease with complex pathological process. Current chemotherapy faces
problems such as lack of specificity, cytotoxicity, induction of multi-drug resistance and stem …

The oral route is the most common route for drug administration. It is the most preferred
route, due to its advantages, such as non-invasiveness, patient compliance and …

Lipid nanoparticles have attracted significant interests in the last two decades, and have
achieved tremendous clinical success since the first clinical approval of Doxil in 1995. At the …

Vaccination is still the most cost-effective way to combat infectious illnesses. Conventional
vaccinations may have low immunogenicity and, in most situations, only provide partial …

The efficacy of current standard chemotherapy is suboptimal due to the poor solubility and
short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of …

Solid lipid nanoparticles (SLNs) are nanocarriers developed as substitute colloidal drug
delivery systems parallel to liposomes, lipid emulsions, polymeric nanoparticles, and so …

NLCs have provoked the incessant impulsion for the development of safe and valuable drug
delivery systems owing to their exceptional physicochemical and then biocompatible …

Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have emerged as
potential drug delivery systems for various applications that are produced from …

Nanostructured lipid carriers (NLCs) are novel pharmaceutical formulations which are
composed of physiological and biocompatible lipids, surfactants and co-surfactants. Over …

Green synthesis of iron nanoparticles is a highly fascinating research area and has gained
importance due to reliable, sustainable and ecofriendly protocol for synthesizing …